Minimal residual disease Antibody drug conjugate Chemotherapy Lymphoma Maintenance chemotherapy Clinical stage Cellular therapy Surgical margin Tyrosine kinase inhibitors (TKIs) PET scan Cure Leukemia Active surveillance Sarcoma Complementary therapy Palliation Complete remission Checkpoint inhibitor Grade 3, 4, or 5 CTCAE Cancer Tumor Partial remission Adjuvant treatment Pathological stage ECOG performance status Adenocarcinoma Refractory TNM staging system Performance status Carcinoma Recurrence or relapse Monoclonal antibody Definitive treatment Liquid tumor Multiple myeloma Neoadjuvant treatment Benign Minimal residual disease Antibody drug conjugate Chemotherapy Lymphoma Maintenance chemotherapy Clinical stage Cellular therapy Surgical margin Tyrosine kinase inhibitors (TKIs) PET scan Cure Leukemia Active surveillance Sarcoma Complementary therapy Palliation Complete remission Checkpoint inhibitor Grade 3, 4, or 5 CTCAE Cancer Tumor Partial remission Adjuvant treatment Pathological stage ECOG performance status Adenocarcinoma Refractory TNM staging system Performance status Carcinoma Recurrence or relapse Monoclonal antibody Definitive treatment Liquid tumor Multiple myeloma Neoadjuvant treatment Benign
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Minimal residual disease
Antibody drug conjugate
Chemotherapy
Lymphoma
Maintenance chemotherapy
Clinical stage
Cellular therapy
Surgical margin
Tyrosine kinase inhibitors (TKIs)
PET scan
Cure
Leukemia
Active surveillance
Sarcoma
Complementary therapy
Palliation
Complete remission
Checkpoint inhibitor
Grade 3, 4, or 5
CTCAE
Cancer
Tumor
Partial remission
Adjuvant treatment
Pathological stage
ECOG performance status
Adenocarcinoma
Refractory
TNM staging system
Performance status
Carcinoma
Recurrence or relapse
Monoclonal antibody
Definitive treatment
Liquid tumor
Multiple myeloma
Neoadjuvant treatment
Benign